Terms: = Brain cancer AND PMS1, hPMS1, 5378, ENSG00000064933, PMSL1, HNPCC3, DKFZp781M0253
11 results:
1. Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
Neth BJ; Raghunathan A; Kizilbash SH; Uhm JH; Breen WG; Johnson DR; Daniels DJ; Sener U; Carabenciov ID; Campian JL; Khatua S; Mahajan A; Ruff MW
Neurology; 2023 Sep; 101(12):e1256-e1271. PubMed ID: 37524533
[TBL] [Abstract] [Full Text] [Related]
2. Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal cancer: A Descriptive Report Focused on Genotype-Phenotype Correlation.
Park JS; Park JW; Shin S; Lee ST; Shin SJ; Min BS; Park SJ; Park JJ; Cheon JH; Kim WH; Kim TI
Dis Colon Rectum; 2022 Jun; 65(6):793-803. PubMed ID: 34897210
[TBL] [Abstract] [Full Text] [Related]
3. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Roncati L
Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
[TBL] [Abstract] [Full Text] [Related]
4. DNA mismatch repair deficiency in lung and oral cavity carcinomas: the role of histogenetic origin.
Spetsotaki KN; Tsiambas E; Stamatelopoulos A; Fotiades PP; Kastanioudakis I; Tomos P; Ragos V
J BUON; 2017; 22(3):606-609. PubMed ID: 28730763
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive interpretation of hyperglycemia and hyperosmolality on the clinical outcomes among ischemic stroke patients.
Ock S; Jo S; Lee JB; Jin Y; Jeong T; Yoon J; Park B
Am J Emerg Med; 2016 Dec; 34(12):2343-2350. PubMed ID: 27614372
[TBL] [Abstract] [Full Text] [Related]
6. The clinicopathological and prognostic features of Chinese and Japanese inpatients with lung cancer.
Gao Y; Zhang JF; Li QC; Liu JJ; Liu LL; Yang XF; Jiang HM; Zheng HC
Oncotarget; 2016 Oct; 7(41):67425-67434. PubMed ID: 27608841
[TBL] [Abstract] [Full Text] [Related]
7. Mismatch repair protein hMSH2 in primary drug resistance in in vitro human malignant gliomas.
Rellecke P; Kuchelmeister K; Schachenmayr W; Schlegel J
J Neurosurg; 2004 Oct; 101(4):653-8. PubMed ID: 15481721
[TBL] [Abstract] [Full Text] [Related]
8. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract] [Full Text] [Related]
9. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.
Tanaka Y; Hongo K; Tada T; Sakai K; Kakizawa Y; Kobayashi S
J Neurosurg; 2003 Feb; 98(2):359-65. PubMed ID: 12593623
[TBL] [Abstract] [Full Text] [Related]
10. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction.
Wei Q; Guan Y; Cheng L; Radinsky R; Bar-Eli M; Tsan R; Li L; Legerski RJ
Pathobiology; 1997; 65(6):293-300. PubMed ID: 9491849
[TBL] [Abstract] [Full Text] [Related]
11. Cloning, characterization and chromosomal assignment of the human genes homologous to yeast pms1, a member of mismatch repair genes.
Horii A; Han HJ; Sasaki S; Shimada M; Nakamura Y
Biochem Biophys Res Commun; 1994 Nov; 204(3):1257-64. PubMed ID: 7980603
[TBL] [Abstract] [Full Text] [Related]
